Imunon Inc (IMNN)
0.9799
+0.03
(+3.15%)
USD |
NASDAQ |
Nov 04, 16:00
0.98
0.00 (0.00%)
Pre-Market: 08:32
Imunon Enterprise Value: 8.805M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 8.805M |
| November 01, 2024 | 8.374M |
| October 31, 2024 | 8.086M |
| October 30, 2024 | 8.517M |
| October 29, 2024 | 8.504M |
| October 28, 2024 | 8.605M |
| October 25, 2024 | 8.050M |
| October 24, 2024 | 7.942M |
| October 23, 2024 | 8.276M |
| October 22, 2024 | 8.665M |
| October 21, 2024 | 8.986M |
| October 18, 2024 | 8.886M |
| October 17, 2024 | 8.788M |
| October 16, 2024 | 9.093M |
| October 15, 2024 | 9.040M |
| October 14, 2024 | 9.526M |
| October 11, 2024 | 9.382M |
| October 10, 2024 | 9.238M |
| October 09, 2024 | 9.310M |
| October 08, 2024 | 9.094M |
| October 07, 2024 | 9.382M |
| October 04, 2024 | 10.25M |
| October 03, 2024 | 9.238M |
| October 02, 2024 | 9.092M |
| October 01, 2024 | 9.958M |
| Date | Value |
|---|---|
| September 30, 2024 | 9.958M |
| September 27, 2024 | 9.670M |
| September 26, 2024 | 9.238M |
| September 25, 2024 | 9.238M |
| September 24, 2024 | 9.526M |
| September 23, 2024 | 9.526M |
| September 20, 2024 | 9.526M |
| September 19, 2024 | 10.10M |
| September 18, 2024 | 11.11M |
| September 17, 2024 | 11.11M |
| September 16, 2024 | 10.25M |
| September 13, 2024 | 9.670M |
| September 12, 2024 | 10.39M |
| September 11, 2024 | 10.61M |
| September 10, 2024 | 10.53M |
| September 09, 2024 | 10.10M |
| September 06, 2024 | 9.670M |
| September 05, 2024 | 9.526M |
| September 04, 2024 | 9.814M |
| September 03, 2024 | 10.97M |
| August 30, 2024 | 11.25M |
| August 29, 2024 | 10.39M |
| August 28, 2024 | 11.11M |
| August 27, 2024 | 11.40M |
| August 26, 2024 | 12.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-24.81M
Minimum
Sep 23 2022
193.65M
Maximum
Feb 22 2021
12.41M
Average
4.668M
Median
Apr 11 2024
Enterprise Value Benchmarks
| Merck & Co Inc | 284.72B |
| Cormedix Inc | 535.86M |
| Brainstorm Cell Therapeutics Inc | 6.099M |
| Predictive Oncology Inc | -0.5069M |
| Outlook Therapeutics Inc | 143.29M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.788M |
| Total Expenses (Quarterly) | 5.013M |
| EPS Diluted (Quarterly) | -0.51 |
| Earnings Yield | -195.9% |
| Normalized Earnings Yield | -433.50 |